Insider Selling: Alignment Healthcare (NASDAQ:ALHC) President Sells $674,400.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 15th. The stock was sold at an average price of $22.48, for a total value of $674,400.00. Following the transaction, the president owned 1,027,015 shares of the company’s stock, valued at $23,087,297.20. This trade represents a 2.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total transaction of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total transaction of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62.

Alignment Healthcare Stock Performance

Alignment Healthcare stock remained flat at $22.50 during trading hours on Friday. 3,345,207 shares of the company’s stock traded hands, compared to its average volume of 2,831,083. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market capitalization of $4.50 billion, a PE ratio of -187.50, a P/E/G ratio of 5.73 and a beta of 1.16. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.19. The stock has a 50 day moving average of $19.08 and a 200-day moving average of $16.76.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. Alignment Healthcare’s quarterly revenue was up 43.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.14) earnings per share. On average, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ALHC. TD Cowen lifted their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $22.00 target price on shares of Alignment Healthcare in a research note on Monday, November 3rd. JPMorgan Chase & Co. increased their price target on shares of Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Finally, Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $21.86.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Integrated Wealth Concepts LLC raised its stake in shares of Alignment Healthcare by 6.3% during the third quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after buying an additional 665 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in Alignment Healthcare by 2.3% in the third quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock worth $659,000 after purchasing an additional 844 shares during the period. Tidal Investments LLC boosted its position in shares of Alignment Healthcare by 4.9% during the second quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock worth $253,000 after purchasing an additional 852 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares during the period. Finally, Jefferies Financial Group Inc. increased its position in shares of Alignment Healthcare by 4.3% in the 3rd quarter. Jefferies Financial Group Inc. now owns 24,359 shares of the company’s stock valued at $425,000 after buying an additional 1,014 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.